Dr. Spaggiari on Surgical Interventions in CRC With Liver Metastases


In Partnership With:

Mario Spaggiari, MD, discusses surgical interventions in colorectal cancer with liver metastases.

Mario Spaggiari, MD, transplant surgeon, Division of Transplantation, University of Illinois Health, discusses surgical interventions in colorectal cancer (CRC) with liver metastases.

It is important to determine what aspects of patient care are handled by each specialty of a multidisciplinary care team, including medical oncology and surgery. In the realm of surgery, a deciding factor for resectability is whether a 30% liver remnant can be left, Spaggiari says. Leaving 30% of the liver means that the liver can regenerate and fulfill metabolic needs.

To determine surgical eligibility, volumetric calculations need to be made, like those needed for liver transplant, Spaggiari says. If the liver remnant is going to be too small, downstaging strategies, such as portal vein embolization, double vein embolization, ALPPS surgery, or two-stage hepatectomy, can be considered.

Moreover, achieving an R0 resection safely can prevent patients from developing small-for-size syndrome or liver insufficiency, Spaggiari concludes.

Related Videos
Petros Grivas, MD, PhD, professor, Clinical Research Division, Fred Hutchinson Cancer Center; professor, Division of Hematology and Oncology, University of Washington (UW) School of Medicine; clinical director, Genitourinary Cancers Program, UW Medicine
Somedeb Ball, MBBS, assistant professor, medicine, Division of Hematology Oncology, Department of Medicine, Vanderbilt University Medical Center
Phillip J. Koo, MD
Gabriella Smith, MD
Mikkael A. Sekeres, MD, MS
Francesco Di Meo, PhD
Ko Un “Clara” Park, MD
Naseema Gangat, MBBS
Erin Frances Cobain, MD
Pashtoon Murtaza Kasi, MD, MS